Roche

dominoes stop stall halt end red
Biotech

Genentech drug fails rare disease study, raising obesity questions

Genentech will not push anti-myostatin antibody emugrobart into phase 3 for two muscle-wasting diseases after it failed to improve muscle growth.
Darren Incorvaia Mar 20, 2026 2:11pm
Stop sign and red lights at traffic intersection

Genentech shreds RIPK1 inhibitor after ph. 2 failure

Mar 19, 2026 2:48pm
New York City St Patricks Day

J&J changes New York state of mind, closing JLABS site

Mar 17, 2026 11:20am
AI artificial intelligence factory cloud

Roche inks Nvidia expansion to bolster AI factory

Mar 16, 2026 5:58pm
failure crash no fail rocket cancelled end

Roche's oral SERD flunks 1st-line breast cancer phase 3

Mar 9, 2026 6:40am
gymnastics

Zealand's Zupreme serves up to 10.7% mean weight loss

Mar 5, 2026 4:44pm